Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8383730rdf:typepubmed:Citationlld:pubmed
pubmed-article:8383730lifeskim:mentionsumls-concept:C0002062lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0032699lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0064847lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C1334350lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0020923lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C0214374lld:lifeskim
pubmed-article:8383730lifeskim:mentionsumls-concept:C1218173lld:lifeskim
pubmed-article:8383730pubmed:issue1lld:pubmed
pubmed-article:8383730pubmed:dateCreated1993-4-15lld:pubmed
pubmed-article:8383730pubmed:abstractTextThree new imidazole alkaloids, leucettamines A [1] and B [2] and leucettamidine [3], have been isolated from the Palauan sponge Leucetta microraphis. Their structures were established on the basis of extensive spectral analyses. Leucettamine A showed potent leukotriene B4 receptor binding activity (K(i) = 1.3 microM), while leucettamine B was essentially inactive (K(i) = 100 microM) and leucettamidine showed significant activity (K(i) = 5.3 microM). With leucettamine A identified as a pure LTB4 receptor antagonist, a new structure lead is presented to inflammation therapy.lld:pubmed
pubmed-article:8383730pubmed:languageenglld:pubmed
pubmed-article:8383730pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:citationSubsetIMlld:pubmed
pubmed-article:8383730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8383730pubmed:statusMEDLINElld:pubmed
pubmed-article:8383730pubmed:monthJanlld:pubmed
pubmed-article:8383730pubmed:issn0163-3864lld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:SarauH MHMlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:WestleyJ WJWlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:MongSSlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:ChanG WGWlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:HemlingM EMElld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:DeBrosseC WCWlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:OffenP HPHlld:pubmed
pubmed-article:8383730pubmed:authorpubmed-author:FreyerA JAJlld:pubmed
pubmed-article:8383730pubmed:issnTypePrintlld:pubmed
pubmed-article:8383730pubmed:volume56lld:pubmed
pubmed-article:8383730pubmed:ownerNLMlld:pubmed
pubmed-article:8383730pubmed:authorsCompleteYlld:pubmed
pubmed-article:8383730pubmed:pagination116-21lld:pubmed
pubmed-article:8383730pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:meshHeadingpubmed-meshheading:8383730-...lld:pubmed
pubmed-article:8383730pubmed:year1993lld:pubmed
pubmed-article:8383730pubmed:articleTitleNew leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge Leucetta microraphis.lld:pubmed
pubmed-article:8383730pubmed:affiliationResearch and Development, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.lld:pubmed
pubmed-article:8383730pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8383730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8383730lld:pubmed